Site-Specific Inhibitors of Histone Methyltransferase [HMTASE] and Process of Preparation Thereof
申请人:Kundu Tapas Kumar
公开号:US20100292498A1
公开(公告)日:2010-11-18
The present invention relates to compounds of structural formula (I) as site-specific inhibitor of histone methyl-transferase, where R
1
and R
1
is —OCH or —OH, R
2
and R
2
is —OH or —OAc; a process of isolating compound of structural formula (Ia), where R
1
and R
1
is —OCH, R
2
and R
2
is —OH; a process of preparation of compound of structural formula (Ib), where R
1
and R
1
is —OCH, R
2
and R
2
is —OAc; a process of preparation of compound of structural formula Ic, where R
1
and R
1
is —OH, R
2
and R
2
is —OH; and use of compounds of structural formula I for manufacture of a medicament for management of cancer and/or disease conditions in a subject in need thereof.
本发明涉及结构式(I)的化合物,作为组织特异性组蛋白甲基转移酶的抑制剂,其中R1和R1是—OCH或—OH,R2和R2是—OH或—OAc;一种分离结构式(Ia)化合物的方法,其中R1和R1是—OCH,R2和R2是—OH;一种制备结构式(Ib)化合物的方法,其中R1和R1是—OCH,R2和R2是—OAc;一种制备结构式Ic化合物的方法,其中R1和R1是—OH,R2和R2是—OH;以及利用结构式I的化合物制造用于治疗癌症和/或疾病病况的药物的用途。